News and Announcements
Fortitude North grows in size as number of significant gold values are returned
- Published January 07, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Significant new assays from recent lake aircore drilling at Fortitude North.
- The new intercepts are in deeply weathered basement rocks.
- Diamond and infill/step out RC drilling is planned ASAP to determine the extent of gold mineralisation.
Significant new Gold assays have been received from recent aircore drilling at Fortitude North.
Fortitude North grows in size and significance from new assay results with a best result of 47m @ 2.55 g/t Au from 42m including 1m @ 84.1g/t from 53m.
The new intercepts are in deeply weathered basement rocks.
The new results are ‘pleasing’ to Executive Chairman, Mr Paul Poli, who believes that Lake Carey offers significant opportunity for new discoveries.
A diamond drilling programme is proposed to determine the nature and extent of gold mineralisation in early 2019.
Matsa holds a ground position of ~ 620km2 at Lake Carey which is highly prospective for new gold
discoveries.
The Company is committed to becoming a mid-tier gold mining company.
About Matsa Resources Limited
Matsa is an ASX listed explorer/developer who has become a gold producer following the acquisition and development of the Fortitude gold mine. Fortitude forms part of the Lake Carey gold project south of Laverton. Matsa has a pipeline of quality projects within Australia and central Thailand. Matsa has recently acquired the Red October Gold mine near Lake Carey which boosts the mining potential within the area.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
